The Effect of the Controversial US Preventive Services Task Force Recommendations on the Use of Screening Mammography

被引:31
作者
Sharpe, Richard E., Jr. [1 ]
Levin, David C. [1 ,2 ]
Parker, Laurence [1 ]
Rao, Vijay M. [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Radiol, Ctr Res Utilizat Imaging Serv, Philadelphia, PA 19107 USA
[2] HealthHelp Inc, Houston, TX USA
关键词
Breast; breast imaging; mammography; utilization; screening; health care economics; Medicare; health policy; USPSTF recommendations; BREAST-CANCER; FOLLOW-UP; MORTALITY; AGE;
D O I
10.1016/j.jacr.2012.07.008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The 2009 release of updated US Preventive Services Task Force (USPSTF) recommendations on screening mammography differed sharply from those of the American Cancer Society, the ACR, and the American College of Obstetricians and Gynecologists. The aim of this study was to ascertain the effect of these recommendations on the utilization of screening mammography in the Medicare population. Methods: The Medicare Part B Physician/Supplier Procedure Summary Master Files from 2005 through 2010 were used to determine the annual utilization rate of screening mammography from 2005 to 2010. A utilization trend line was plotted for those years. Results: The utilization rate of screening mammography per 1,000 women in the Medicare population was 311.6 in 2005 and increased gradually each year to 322.9 in 2009 (a compound annual growth rate of 0.9%). However, after the USPSTF recommendations were issued in late 2009, this rate decreased abruptly to 309.1 (-4.3%) in 2010. Conclusions: The abrupt decrease in the utilization of screening mammography in 2010 was in sharp contrast to the previous slow annual increases in its utilization from 2005 to 2009. Because there are no other factors to explain a decrease of this magnitude, it would seem that the USPSTF recommendations and the ensuing publicity resulted in a decrease in the utilization of screening mammography in the Medicare population in the first year after issuance of the new recommendations.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 35 条
[1]  
Alexander F E, 1997, J Natl Cancer Inst Monogr, P31
[2]   14 years of follow-up from the Edinbugh randomised trial of breast-cancer screening [J].
Alexander, FE ;
Anderson, TJ ;
Brown, HK ;
Forrest, APM ;
Hepburn, W ;
Kirkpatrick, AE ;
Muir, BB ;
Prescott, RJ ;
Smith, A .
LANCET, 1999, 353 (9168) :1903-1908
[3]  
American College of Radiology, ACR PRACT GUID PERF
[4]  
American College of Surgeons, AM COLL SURG VOIC ST
[5]  
American Society of Breast Disease, AM SOC BREAST DIS EN
[6]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[7]  
Andersson I, 1997, J Natl Cancer Inst Monogr, P63
[8]  
[Anonymous], WASHINGTON POST
[9]  
[Anonymous], 1991, CANC SCREENING
[10]  
[Anonymous], AM CANC SOC GUID EAR